Physician

Ovidiu George Negrea, M.D.

According to 2025 Medicare claims, Ovidiu Negrea, M.D. (NPI: 1457319931) practices hematology/oncology in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 31404-6220.

Negrea's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,272 traditional Medicare patients, billed 245,412 HCPCS/CPT codes, and received $5,174,729 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,437 prescription claims across 574 beneficiaries totaling $12,597,968 in drug costs, led by Revlimid (Lenalidomide). DME data shows 119 claims. Open Payments data shows 7 records totaling $28,235. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,852,006 to $5,174,729. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,438,372 to $12,597,968. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,916 to $1,600.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,063	217,212	$1,852,006
2016	1,109	181,935	$1,864,188
2017	1,120	172,732	$2,195,211
2018	1,173	270,652	$2,625,563
2019	1,362	314,342	$2,919,870
2020	1,371	296,910	$3,106,963
2021	1,381	266,674	$4,309,399
2022	1,252	196,597	$3,962,291
2023	1,269	220,531	$4,059,922
2024	1,272	245,412	$5,174,729

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	301	2,124	$2,438,372
2016	288	2,133	$3,452,567
2017	330	2,370	$4,167,339
2018	395	2,723	$4,512,761
2019	420	2,923	$4,944,206
2020	496	3,318	$7,329,035
2021	487	2,953	$8,542,589
2022	461	2,535	$8,331,653
2023	518	2,759	$9,424,978
2024	574	3,437	$12,597,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	43	189	$57,833
2016	N/R	90	$27,331
2017	12	81	$26,209
2018	15	173	$20,332
2019	15	183	$11,069
2020	11	307	$21,837
2021	N/R	223	$16,911
2022	14	119	$5,762
2023	13	109	$20,217
2024	N/R	119	$5,969

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	337	549	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	719	1,158	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	174	192	$12
36415	Insertion of needle into vein for collection of blood sample	846	2,280	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	844	2,650	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	149	4,165	$2,768,769
Brukinsa	Zanubrutinib	102	3,060	$1,475,603
Cabometyx	Cabozantinib S-Malate	48	1,385	$1,140,692
Ibrance	Palbociclib	60	1,680	$912,498
Pomalyst	Pomalidomide	38	1,059	$808,093

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	11	$2,985
J8700	Temozolomide, oral, 5 mg	N	N/R	11	$821
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	43	$809
J8521	Capecitabine, oral, 500 mg	N	N/R	27	$749
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	13	$429

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$351	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$27,885	Memorial Health Univ Med Center
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ovidiu George Negrea, M.D.?

Tedicare shows public-source Medicare data for Ovidiu George Negrea, M.D. (NPI 1457319931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ovidiu George Negrea, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ovidiu George Negrea, M.D.?

Ovidiu George Negrea, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Ovidiu George Negrea, M.D. have Open Payments data?

Ovidiu George Negrea, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.